AI Article Synopsis
- Acute portomesenteric venous thrombosis (PVT) is a serious condition that can occur in individuals without liver cirrhosis, requiring careful management.
- Initial treatment often involves anticoagulation therapy, but researchers are still investigating the best interventional techniques available.
- The article also examines the relevance of acute PVT in today's health issues, including its connections to COVID-19, vaccine-related blood clots, and liver transplantation.
Article Abstract
Acute portomesenteric venous thrombosis (PVT) is a rare but potentially life-threatening condition in individuals without cirrhosis. Initial management typically involves anticoagulation therapy, but the optimal approach to interventional treatment remains a topic of ongoing research. This article explores both traditional and emerging endovascular techniques, providing an overview of the existing evidence supporting their use. Additionally, it delves into the significance of acute PVT in the context of contemporary pathologies, notably coronavirus disease 2019 infection, vaccine-induced immune thrombotic thrombocytopenia, and liver transplantation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvir.2024.09.023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!